See the DrugPatentWatch profile for Roflumilast
Roflumilast, a medication used to treat severe chronic obstructive pulmonary disease (COPD), has a retail price that can vary significantly based on factors such as insurance coverage, pharmacy, and dosage. Information regarding the precise retail price is best obtained from specific pharmacies or by consulting with healthcare providers who can offer details on available patient assistance programs.
How much does Roflumilast cost without insurance?
The cost of roflumilast without insurance can be substantial. For example, a 30-count prescription of 500 mcg tablets has been reported to cost upwards of $400, though this price can fluctuate [1]. This highlights the importance of exploring discount programs and patient assistance if insurance is not available.
Are there ways to get Roflumilast at a lower cost?
Several avenues exist for potentially lowering the cost of roflumilast. Manufacturer-sponsored patient assistance programs may offer financial support to eligible individuals who lack adequate insurance coverage. Additionally, discount cards and coupons distributed by pharmaceutical companies or available through online platforms can provide savings at the pharmacy. Comparing prices across different pharmacies is also a common strategy to find a more affordable option [1].
When does the patent for Roflumilast expire?
The patent landscape for roflumilast is complex and involves multiple patents covering different aspects of the drug, including its composition and methods of use. For precise details on patent expiry dates, which can influence the availability of generic versions and subsequent pricing, consulting specialized resources like DrugPatentWatch.com is recommended [2].
Can I get a generic version of Roflumilast?
The availability of generic versions of roflumilast is contingent upon patent expiries and regulatory approvals. Once patents expire and generic manufacturers receive approval from regulatory bodies, generic alternatives typically become available, often at a lower price point than the brand-name drug. Information on the status of generic approvals and expected entry dates can be found through patent databases and pharmaceutical regulatory agency websites.
What is Roflumilast used for?
Roflumilast is a phosphodiesterase-4 (PDE4) inhibitor prescribed to reduce the risk of exacerbations in patients with severe COPD associated with chronic bronchitis. It works by decreasing inflammation in the lungs, which helps to improve breathing [3].
What are the side effects of Roflumilast?
Common side effects associated with roflumilast include diarrhea, nausea, weight loss, and insomnia. Less common but potentially serious side effects may also occur. Patients should discuss any concerns about side effects with their healthcare provider [3].
Sources:
1. https://www.goodrx.com/roflumilast
2. https://drugpatentwatch.com/
3. https://www.mayoclinic.org/drugs-supplements/roflumilast-oral-route/description/drg-20075673